Hub Genes Associated with the Diagnosis of Diabetic Retinopathy

References

• Ndjaboue R, Farhat I, Ferlatte CA, et al. Predictive models of diabetes complications: protocol for a scoping review. Syst Rev. 2020;9(1):137. doi:10.1186/s13643-020-01391-w
   PubMed Web of Science ®Google Scholar
• Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. doi:10.1016/j.diabres.2017.03.024
   PubMed Web of Science ®Google Scholar
• Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023
   PubMed Web of Science ®Google Scholar
• Santiago AR, Boia R, Aires ID, Ambrosio AF, Fernandes R. Sweet stress: coping with vascular dysfunction in diabetic retinopathy. Front Physiol. 2018;9:820. doi:10.3389/fphys.2018.00820
   PubMed Web of Science ®Google Scholar
• Altmann C, Schmidt MHH. The role of microglia in diabetic retinopathy: inflammation, microvasculature defects and neurodegeneration. Int J Mol Sci. 2018;19(1). doi:10.3390/ijms19010110
   PubMed Web of Science ®Google Scholar
• Rossino MG, Dal Monte M, Casini G. Relationships between neurodegeneration and vascular damage in diabetic retinopathy. Front Neurosci. 2019;13:1172. doi:10.3389/fnins.2019.01172
   PubMed Web of Science ®Google Scholar
• Fong DS, Aiello L, Gardner TW, et al. Retinopathy in diabetes. Diabetes Care. 2004;27(Suppl 1):S84–87. doi:10.2337/diacare.27.2007.S84
   PubMed Web of Science ®Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564. doi:10.2337/dc11-1909
   PubMed Web of Science ®Google Scholar
• Simo R, Stitt AW, Gardner TW. Neurodegeneration in diabetic retinopathy: does it really matter? Diabetologia. 2018;61(9):1902–1912. doi:10.1007/s00125-018-4692-1
   PubMed Web of Science ®Google Scholar
• Schmier JK, Covert DW, Lau EC, Matthews GP. Medicare expenditures associated with diabetes and diabetic retinopathy. Retina. 2009;29(2):199–206. doi:10.1097/IAE.0b013e3181884f2d
   PubMed Web of Science ®Google Scholar
• Colin J, Le Gall G, Le Jeune B, Cambrai MD. The prevalence of exfoliation syndrome in different areas of France. Acta Ophthalmol Suppl. 1988;184:86–89. doi:10.1111/j.1755-3768.1988.tb02634.x
   PubMedGoogle Scholar
• Caprara C, Grimm C. From oxygen to erythropoietin: relevance of hypoxia for retinal development, health and disease. Prog Retin Eye Res. 2012;31(1):89–119.
   PubMed Web of Science ®Google Scholar
• Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366(13):1227–1239. doi:10.1056/NEJMra1005073
   PubMed Web of Science ®Google Scholar
• Kowluru RA. Diabetic retinopathy, metabolic memory and epigenetic modifications. Vision Res. 2017;139:30–38. doi:10.1016/j.visres.2017.02.011
   PubMed Web of Science ®Google Scholar
• Jenkins AJ, Joglekar MV, Hardikar AA, Keech AC, O’Neal DN, Januszewski AS. Biomarkers in Diabetic Retinopathy. Rev Diabet Stud. 2015;12(1–2):159–195. doi:10.1900/RDS.2015.12.159
   PubMedGoogle Scholar
• Potilinski MC, Lorenc V, Perisset S, Gallo JE. Mechanisms behind retinal ganglion cell loss in diabetes and therapeutic approach. Int J Mol Sci. 2020;21(7). doi:10.3390/ijms21072351
   PubMed Web of Science ®Google Scholar
• Stitt AW, Lois N, Medina RJ, Adamson P, Curtis TM. Advances in our understanding of diabetic retinopathy. Clin Sci (Lond). 2013;125(1):1–17. doi:10.1042/CS20120588
   PubMed Web of Science ®Google Scholar
• Das A, Stroud S, Mehta A, Rangasamy S. New treatments for diabetic retinopathy. Diabetes Obes Metab. 2015;17(3):219–230. doi:10.1111/dom.12384
   PubMed Web of Science ®Google Scholar
• Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350(1):48–58. doi:10.1056/NEJMra021678
   PubMed Web of Science ®Google Scholar
• Pardue MT, Allen RS. Neuroprotective strategies for retinal disease. Prog Retin Eye Res. 2018;65:50–76.
   PubMed Web of Science ®Google Scholar
• Agardh E, Lundstig A, Perfilyev A, et al. Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy. BMC Med. 2015;13:182. doi:10.1186/s12916-015-0421-5
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications (DCCT) Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int. 1995;47(6):1703–1720. doi:10.1038/ki.1995.236
   PubMed Web of Science ®Google Scholar
• Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics. 2008;24(13):1547–1548. doi:10.1093/bioinformatics/btn224
   PubMed Web of Science ®Google Scholar
• Nathan DM, Bayless M, Cleary P, et al. Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes. 2013;62(12):3976–3986. doi:10.2337/db13-1093
   PubMed Web of Science ®Google Scholar
• Tian Y, Morris TJ, Webster AP, et al. ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics. 2017;33(24):3982–3984. doi:10.1093/bioinformatics/btx513
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Bandettini WP, Kellman P, Mancini C, et al. MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study. J Cardiovasc Magn Reson. 2012;14:83. doi:10.1186/1532-429X-14-83
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Sergushichev AAJB. An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation. bioRxiv. 2016;060012.
   Google Scholar
• Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7. doi:10.1186/1471-2105-14-7
   PubMed Web of Science ®Google Scholar
• Ernst J, Bar-Joseph Z. STEM: a tool for the analysis of short time series gene expression data. BMC Bioinform. 2006;7:191. doi:10.1186/1471-2105-7-191
   PubMed Web of Science ®Google Scholar
• Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77. doi:10.1186/1471-2105-12-77
   PubMed Web of Science ®Google Scholar
• Bindea G, Mlecnik B, Tosolini M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782–795. doi:10.1016/j.immuni.2013.10.003
   PubMed Web of Science ®Google Scholar
• Jayson GC, Zhou C, Backen A, et al. Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer. Nat Commun. 2018;9(1):4672. doi:10.1038/s41467-018-07174-1
   PubMed Web of Science ®Google Scholar
• Constancio V, Nunes SP, Henrique R, Jeronimo C. DNA methylation-based testing in liquid biopsies as detection and prognostic biomarkers for the four major cancer types. Cells. 2020;9(3). doi:10.3390/cells9030624
   PubMed Web of Science ®Google Scholar
• Wu L, Guo F, Wu Y, et al. The role of FoxO1 in interleukin-1beta-induced autostimulation in retina endothelial cells and retinas of diabetic rats. Microvasc Res. 2017;112:93–100. doi:10.1016/j.mvr.2017.03.003
   PubMed Web of Science ®Google Scholar
• Shan S, Chatterjee A, Qiu Y, Hammes HP, Wieland T, Feng Y. O-GlcNAcylation of FoxO1 mediates nucleoside diphosphate kinase B deficiency induced endothelial damage. Sci Rep. 2018;8(1):10581. doi:10.1038/s41598-018-28892-y
   PubMed Web of Science ®Google Scholar
• Nakae J, Oki M, Cao Y. The FoxO transcription factors and metabolic regulation. FEBS Lett. 2008;582(1):54–67. doi:10.1016/j.febslet.2007.11.025
   PubMed Web of Science ®Google Scholar
• Inoki K. Role of TSC-mTOR pathway in diabetic nephropathy. Diabetes Res Clin Pract. 2008;82(Suppl 1):S59–62. doi:10.1016/j.diabres.2008.09.028
   PubMed Web of Science ®Google Scholar
• Prado MSG, de Jesus ML, de Goes TC, Mendonca LSO, Kaneto CM. Downregulation of circulating miR-320a and target gene prediction in patients with diabetic retinopathy. BMC Res Notes. 2020;13(1):155. doi:10.1186/s13104-020-05001-9
   PubMed Web of Science ®Google Scholar
• Louie CM, Caridi G, Lopes VS, et al. AHI1 is required for photoreceptor outer segment development and is a modifier for retinal degeneration in nephronophthisis. Nat Genet. 2010;42(2):175–180. doi:10.1038/ng.519
   PubMed Web of Science ®Google Scholar
• Muruganandan S, Govindarajan R, McMullen NM, Sinal CJ. Chemokine-like receptor 1 is a novel wnt target gene that regulates mesenchymal stem cell differentiation. Stem Cells. 2017;35(3):711–724. doi:10.1002/stem.2520
   PubMed Web of Science ®Google Scholar
• Gu P, Wang W, Yao Y, et al. Increased circulating chemerin in relation to chronic microvascular complications in patients with Type 2 diabetes. Int J Endocrinol. 2019;2019:8693516. doi:10.1155/2019/8693516
   PubMed Web of Science ®Google Scholar
• Li C, Wei B, Zhao J. Competing endogenous RNA network analysis explores the key lncRNAs, miRNAs, and mRNAs in type 1 diabetes. BMC Med Genomics. 2021;14(1):35. doi:10.1186/s12920-021-00877-3
   PubMed Web of Science ®Google Scholar
• Brenner LN, Mercader JM, Robertson CC, et al. Analysis of glucocorticoid-related genes reveal CCHCR1 as a new candidate gene for Type 2 diabetes. J Endocr Soc. 2020;4(11):bvaa121. doi:10.1210/jendso/bvaa121
   PubMed Web of Science ®Google Scholar
• Mindikoglu AL, Abdulsada MM, Jain A, et al. Intermittent fasting from dawn to sunset for four consecutive weeks induces anticancer serum proteome response and improves metabolic syndrome. Sci Rep. 2020;10(1):18341. doi:10.1038/s41598-020-73767-w
   PubMed Web of Science ®Google Scholar
• Oakley RH, Busillo JM, Cidlowski JA. Cross-talk between the glucocorticoid receptor and MyoD family inhibitor domain-containing protein provides a new mechanism for generating tissue-specific responses to glucocorticoids. J Biol Chem. 2017;292(14):5825–5844. doi:10.1074/jbc.M116.758888
   PubMed Web of Science ®Google Scholar
• Su T, Gu C, Draga D, et al. Integrative analysis of miRNA-mRNA network in high altitude retinopathy by bioinformatics analysis. Biosci Rep. 2021;41(1). doi:10.1042/BSR20200776.
   Web of Science ®Google Scholar
• Cecilia OM, Jose Alberto CG, Jose NP, et al. Oxidative stress as the main target in diabetic retinopathy pathophysiology. J Diabetes Res. 2019;2019:8562408. doi:10.1155/2019/8562408
   PubMed Web of Science ®Google Scholar
• Nieves-Cintron M, Syed AU, Nystoriak MA, Navedo MF. Regulation of voltage-gated potassium channels in vascular smooth muscle during hypertension and metabolic disorders. Microcirculation. 2018;25(1). doi:10.1111/micc.12423
   PubMed Web of Science ®Google Scholar
• Martin-Aragon Baudel M, Espinosa-Tanguma R, Nieves-Cintron M, Navedo MF. Purinergic signaling during hyperglycemia in vascular smooth muscle cells. Front Endocrinol (Lausanne). 2020;11:329. doi:10.3389/fendo.2020.00329
   PubMed Web of Science ®Google Scholar
• Liu Z, Khalil RA. Evolving mechanisms of vascular smooth muscle contraction highlight key targets in vascular disease. Biochem Pharmacol. 2018;153:91–122.
   PubMed Web of Science ®Google Scholar
• Rubsam A, Parikh S, Fort PE. Role of inflammation in diabetic retinopathy. Int J Mol Sci. 2018;19(4). doi:10.3390/ijms19040942
   PubMed Web of Science ®Google Scholar
• Li Y, Sun R, Zou J, Ying Y, Luo Z. Dual roles of the AMP-Activated protein kinase pathway in angiogenesis. Cells. 2019;8(7).
   Web of Science ®Google Scholar
• Joussen AM, Poulaki V, Qin W, et al. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol. 2002;160(2):501–509. doi:10.1016/S0002-9440(10)64869-9
   PubMed Web of Science ®Google Scholar
• Cachafeiro M, Bemelmans AP, Samardzija M, et al. Hyperactivation of retina by light in mice leads to photoreceptor cell death mediated by VEGF and retinal pigment epithelium permeability. Cell Death Dis. 2013;4:e781. doi:10.1038/cddis.2013.303
   PubMed Web of Science ®Google Scholar
• Zhao M, Li CH, Liu YL. Toll-like receptor (TLR)-2/4 expression in retinal ganglion cells in a high-glucose environment and its implications. Genet Mol Res. 2016;15(2).
   Web of Science ®Google Scholar
• Kastelan S, Oreskovic I, Biscan F, Kastelan H, Gverovic Antunica A. Inflammatory and angiogenic biomarkers in diabetic retinopathy. Biochem Med (Zagreb). 2020;30(3):030502. doi:10.11613/BM.2020.030502
   PubMed Web of Science ®Google Scholar
• Martins B, Amorim M, Reis F, Ambrosio AF, Fernandes R. Extracellular vesicles and MicroRNA: putative role in diagnosis and treatment of diabetic retinopathy. Antioxidants (Basel). 2020;9(8). doi:10.3390/antiox9080705
   Google Scholar
• Li P, Chen D, Cui Y, et al. Src plays an important role in AGE-Induced endothelial cell proliferation, migration, and tubulogenesis. Front Physiol. 2018;9:765. doi:10.3389/fphys.2018.00765
   PubMed Web of Science ®Google Scholar
• Yeh SH, Chang WC, Chuang H, Huang HC, Liu RT, Yang KD. Differentiation of type 2 diabetes mellitus with different complications by proteomic analysis of plasma low abundance proteins. J Diabetes Metab Disord. 2015;15:24. doi:10.1186/s40200-016-0246-6
   PubMedGoogle Scholar
• Jian L, Yang G. Identification of key genes involved in diabetic peripheral neuropathy progression and associated with pancreatic cancer. Diabetes Metab Syndr Obes. 2020;13:463–476. doi:10.2147/DMSO.S235011
   PubMed Web of Science ®Google Scholar
• Li J, Lu Q, Lu P. Quantitative proteomics analysis of vitreous body from type 2 diabetic patients with proliferative diabetic retinopathy. BMC Ophthalmol. 2018;18(1):151. doi:10.1186/s12886-018-0821-3
   PubMed Web of Science ®Google Scholar
• Howson JM, Roy MS, Zeitels L, Stevens H, Todd JA. HLA class II gene associations in African American type 1 diabetes reveal a protective HLA-DRB1*03 haplotype. Diabet Med. 2013;30(6):710–716. doi:10.1111/dme.12148
   PubMed Web of Science ®Google Scholar
• Lipner EM, Tomer Y, Noble JA, et al. HLA class I and II alleles are associated with microvascular complications of type 1 diabetes. Hum Immunol. 2013;74(5):538–544. doi:10.1016/j.humimm.2013.01.013
   PubMed Web of Science ®Google Scholar
• Wang L, Hiler D, Xu B, et al. Retinal Cell Type DNA Methylation and histone modifications predict reprogramming efficiency and retinogenesis in 3D organoid cultures. Cell Rep. 2018;22(10):2601–2614. doi:10.1016/j.celrep.2018.01.075
   PubMed Web of Science ®Google Scholar
• Kang Q, Yang C. Oxidative stress and diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol. 2020;37:101799.
   PubMed Web of Science ®Google Scholar
• Lopez-Contreras AK, Martinez-Ruiz MG, Olvera-Montano C, et al. Importance of the use of oxidative stress biomarkers and inflammatory profile in aqueous and vitreous humor in diabetic retinopathy. Antioxidants (Basel). 2020;9(9). doi:10.3390/antiox9090891.
   PubMedGoogle Scholar
• Barrett EJ, Liu Z, Khamaisi M, et al. Diabetic microvascular disease: an endocrine society scientific statement. J Clin Endocrinol Metab. 2017;102(12):4343–4410.
   PubMed Web of Science ®Google Scholar